Health economics

Cost-effectiveness study of prophylaxis with emicizumab versus bypassing agents in patients with severe hemophilia A in Peru

Ricardo Bitrán, Camila Peña, Paula Arpón, Nancy Loayza, Katia Salas, Carmen del Villar, Gloria Chumpitaz, Virgilio Salinas

Medwave 2022;22(02):e002118

(15/03/2022)

Cost-utility analysis: Mechanical thrombectomy plus thrombolysis in ischemic stroke due to large vessel occlusion in the public sector in Chile

Rony Lenz-Alcayaga, Daniela Paredes-Fernández, Karla Hernández-Sánchez, Juan E. Valencia-Zapata

Medwave 2021;21(03):e8152

(13/04/2021)

Economic evaluation in health: Cost-utility of the incorporation of total knee replacement to the Chilean Explicit Health-Guarantees regime

Rony Lenz-Alcayaga, Daniela Paredes-Fernández, Diego Edwards-Silva, Pablo Gálvez-Ortega

Medwave 2020;20(11):e8086

(16/12/2020)